APO 250 Pill - brown round, 11mm
Pill with imprint APO 250 is Brown, Round and has been identified as Gefitinib 250 mg.
Gefitinib is used in the treatment of Non-Small Cell Lung Cancer and belongs to the drug class EGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Gefitinib 250 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for APO 250
Gefitinib
- Imprint
- APO 250
- Strength
- 250 mg
- Color
- Brown
- Size
- 11.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- EGFR inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Manufacturer
- Apotex Corporation
- National Drug Code (NDC)
- 60505-4512
Related images for "APO 250"
More about gefitinib
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (8)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: EGFR inhibitors
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
